ALIQOPA is a kinase inhibitor indicated for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies.
Accelerated approval was granted for this indication based on overall response rate.
Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
Please contact at +91 9910645395 or send your enquiry at info@cancermedicinesnetwork to find the price of ALIQOPA (copanlisib) For Injection in Vietnam, Philippines and Ireland. We take guarantee of quality and delivery as per the buyer’s requirements.
Dear Rakesh and Colleagues,
We are very happy to let you know that, just after three weeks, there is no trace of the sickness anymore: your medicine did the job very well!
We will always remember with great pleasure your warm welcoming in Delhi! We would like to thank you very much and wish you all the best. In the coming future we will be delighted to suggest your company to other patients.
Sir, As a first time buyer of an iported drug I'm imressed with your company in procurement of the drug from Canada through the shipping time of 11 to 12 days is quite long to wait. Mr Rajesh Kanan your coordinator has been very helpful and cooperative to my many queries. He is always responsive to my SMS, Whatsapp, email and phone calls. Hoping that the good trend will continue in the future. There is some miscommunications with the TNT courier with my first delivery. Hope that will be solved in the second delivery.
Verve Biosciences connects buyer with the supplier who can ship ALIQOPA (copanlisib) For Injection medications to any country of the world as per the buyer's requirement and Government regulations of the country. We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Verve Biosciences facilitates import of anti-cancer medicines ALIQOPA (copanlisib) Send your enquiry to find the cost of ALIQOPA (copanlisib) in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. "